Importer of Controlled Substances; Notice of Registration; Meridian Medical Technologies, 30331 [2013-12121]

Download as PDF 30331 Federal Register / Vol. 78, No. 99 / Wednesday, May 22, 2013 / Notices in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedules I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12117 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Meridian Medical Technologies By Notice dated March 7, 2012, and published in the Federal Register on March 13, 2013, 78 FR 15974, Meridian Medical Technologies, 2555 Hermelin Drive, St. Louis, Missouri 63144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Morphine (9300), a basic class of controlled substance listed in schedule II. The company manufactures a product containing morphine in the United States. The company exports this product to customers around the world. The company has been asked to ensure that its product sold to European customers meets standards established by the European Pharmacopeia, which is administered by the Directorate of the Quality of Medicines (EDQM). In order to ensure that its product will meet European specifications, the company seeks to import morphine supplied by EDQM to use as reference standards. This is the sole purpose for which the company will be authorized by DEA to import morphine. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Meridian Medical Technologies to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Meridian Medical Technologies to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR § 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. Dated: May 14, 2013. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2013–12121 Filed 5–21–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Alltech Associates, Inc. Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 28, 2013, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: TKELLEY on DSK3SPTVN1PROD with NOTICES Drug Schedule Methcathinone (1237) .................................................................................................................................................................................. N-Ethylamphetamine (1475) ........................................................................................................................................................................ N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. 4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 2C-T-7 (2,5-Dimethoxy-4-(n)-Propylthiophenethylamine) (7348) ................................................................................................................ Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Mescaline (7381) ......................................................................................................................................................................................... 2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine)(7385) ................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. 2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ 2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ 3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ 3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ 4-Methoxyamphetamine (7411) ................................................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine (7431) ................................................................................................................................................. Alpha-methyltryptamine (7432) ................................................................................................................................................................... Bufotenine (7433) ........................................................................................................................................................................................ Diethyltryptamine (7434) ............................................................................................................................................................................. Dimethyltryptamine (7435) .......................................................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... Psilocyn (7438) ............................................................................................................................................................................................ 5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... VerDate Mar<15>2010 16:59 May 21, 2013 Jkt 229001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\22MYN1.SGM 22MYN1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Page 30331]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12121]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Meridian Medical Technologies

    By Notice dated March 7, 2012, and published in the Federal 
Register on March 13, 2013, 78 FR 15974, Meridian Medical Technologies, 
2555 Hermelin Drive, St. Louis, Missouri 63144, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Morphine (9300), a basic class of controlled 
substance listed in schedule II.
    The company manufactures a product containing morphine in the 
United States. The company exports this product to customers around the 
world. The company has been asked to ensure that its product sold to 
European customers meets standards established by the European 
Pharmacopeia, which is administered by the Directorate of the Quality 
of Medicines (EDQM). In order to ensure that its product will meet 
European specifications, the company seeks to import morphine supplied 
by EDQM to use as reference standards. This is the sole purpose for 
which the company will be authorized by DEA to import morphine.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Meridian Medical Technologies to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Meridian 
Medical Technologies to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR Sec.  1301.34, the above named company is 
granted registration as an importer of the basic class of controlled 
substance listed.

    Dated: May 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-12121 Filed 5-21-13; 8:45 am]
BILLING CODE 4410-09-P